Please try another search
Verisante Technology, Inc. is a medical device company focusing on commercializing systems for the early detection of cancer. The Company's device, called the Verisante Aura can be used in the early detection of all forms of skin cancer, including basal cell and squamous cell carcinoma and melanoma. The Verisante Core device is based on the same platform technology as the Aura and can be used in the early detection of lung, cervical, gastrointestinal and colorectal cancers. Verisante Aura is a spectroscopy system designed to aid in the detection of skin cancer. This system provides information about the chemical composition of the skin non-invasively. Aura scans for different spectral markers. Verisante Core uses an endoscopic attachment to aid in the detection of lung, colon, cervical, and other cancers. It has completed a second Phase prototype of a rapid Multispectral Imaging camera (MSI) system for skin cancer detection.
Name | Age | Since | Title |
---|---|---|---|
Jake J. Thiessen | 80 | 2009 | Independent Director |
Harvey Lui | 62 | - | Member of Clinical Advisory Board |
Kenneth Beer | - | 2014 | Member of Clinical Advisory Board |
Wm Philip Werschler | - | 2014 | Member of Clinical Advisory Board |
Emmeline Braun | - | 2021 | CFO, Corporate Secretary & Director |
Thomas A. Braun | 55 | 2006 | President, CEO, Founder & Director |
Vincent Trinh | - | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review